Correlation Between Adicet Bio and Neoleukin Therapeutics

Can any of the company-specific risk be diversified away by investing in both Adicet Bio and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adicet Bio and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adicet Bio and Neoleukin Therapeutics, you can compare the effects of market volatilities on Adicet Bio and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adicet Bio with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adicet Bio and Neoleukin Therapeutics.

Diversification Opportunities for Adicet Bio and Neoleukin Therapeutics

0.62

Correlation Coefficient

Adicet Bio  Neoleukin Therapeutics

Poor diversification

The 3 months correlation between Adicet and Neoleukin is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Adicet Bio and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Adicet Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adicet Bio are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Adicet Bio i.e., Adicet Bio and Neoleukin Therapeutics go up and down completely randomly.

Pair Corralation between Adicet Bio and Neoleukin Therapeutics

Given the investment horizon of 90 days Adicet Bio is expected to under-perform the Neoleukin Therapeutics. In addition to that, Adicet Bio is 1.19 times more volatile than Neoleukin Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Neoleukin Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest  51.00  in Neoleukin Therapeutics on September 24, 2024 and sell it today you would earn a total of  18.00  from holding Neoleukin Therapeutics or generate 35.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	28.11%
Values	Daily Returns

Adicet Bio  vs.  Neoleukin Therapeutics

Adicet Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Adicet Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Neoleukin Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neoleukin Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Neoleukin Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Adicet Bio and Neoleukin Therapeutics

The main advantage of trading using opposite Adicet Bio and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adicet Bio position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.

The idea behind Adicet Bio and Neoleukin Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.